US$1M Backs Singapore’s Push for Proactive Healthcare

Written by

Singapore Medtech Startup Raises US$1M to Shift Healthcare from Reactive to Proactive

Singapore, Singapore – April 15, 2026 / PROTOCOL HEALTH PTE. LTD. /

SINGAPORE – PROTOCOL (protocolhealth.sg), a medtech company dedicated to making preventive and chronic care proactive, personal, and grounded in real clinical data, has announced the successful close of US$1 million in pre-seed funding. The round was led by DSG Consumer Partners, with participation from Lightspeed Venture Partners. The capital will be directed toward expanding PROTOCOL’s clinical and operations team, accelerating development of its proprietary health analytics platform, and scaling customer acquisition throughout Singapore.

Singapore presents a striking healthcare paradox: despite ranking among the world’s longest-lived populations, the country’s healthy life expectancy trails total lifespan by nearly a decade. One in three residents already lives with hypertension or hyperlipidaemia, and chronic disease prevalence is expected to continue rising as the population ages. The central challenge Singapore now faces is not simply adding years to life, but ensuring those years are lived in good health.

Despite meaningful advances in diagnostics and treatment, the vast majority of healthcare delivery remains reactive. Most patients engage with the system only after symptoms emerge, at which point conditions are frequently more difficult and more costly to manage. Preventive care does exist, but it remains deeply fragmented – bloodwork from one provider, prescriptions from another, and lifestyle guidance from a third. No single entity owns the longitudinal health relationship with the patient.

PROTOCOL was built to address that gap directly. By combining comprehensive screening, prescription therapies, and personalised coaching into one integrated care model, the company delivers a continuous, data-driven health relationship rather than isolated episodes of care.

At its core, PROTOCOL is reimagining what a health check-up can be – transforming it from a one-time event into an ongoing relationship. Operating as a hybrid care model, PROTOCOL combines a physical clinic located at 71 Robinson Road, #01-02, Singapore, with a digital-first platform. The company’s approach is grounded in the belief that the best health outcomes demand flexibility: face-to-face consultations when clinical nuance is essential, and seamless digital delivery when convenience and speed are priorities.

Every PROTOCOL member receives access to a dedicated care team consisting of doctors, nutritionists, and health coaches, all fully licensed by the Singapore Medical Council and regulated by the Ministry of Health and Health Sciences Authority. The team goes beyond simply running tests – they explain what the results mean, what is driving them, and what steps members should take. The bloodwork is the starting point. The ongoing relationship is the product. That care relationship is supported by a suite of clinical services:

Core Health Test

Advanced bloodwork panels tracking over 100 biomarkers across metabolic, hormonal, inflammatory, and organ function categories, with a built-in 6-month re-test to monitor progress and identify changes early.

GLP-1 Weight Management

Clinician-supervised GLP-1 receptor agonist therapy for medically appropriate patients, integrated with continuous monitoring and dose optimisation throughout the program.

Testosterone Replacement Therapy (TRT)

Evidence-based TRT protocols for patients presenting with clinically low testosterone, managed through regular bloodwork reviews and ongoing physician oversight.

Targeted Supplementation

Clinically validated probiotic and micronutrient protocols prescribed on the basis of individual bloodwork findings rather than one-size-fits-all recommendations.

Every service feeds into PROTOCOL’s proprietary health dashboard, currently in beta, which gives members real-time visibility into their bloodwork results, trends, and clinical recommendations. New features are being introduced monthly as the platform moves toward becoming each member’s central health record.

PROTOCOL was founded by Mehdi Elaichouni, who was diagnosed with Crohn’s disease at age 17. That experience introduced him early to the difference between feeling “okay” and being genuinely healthy. “What changed everything for me was not chasing fixes, but understanding my body better. Through data, doctors, and consistent lifestyle changes in nutrition, sleep, stress, and training, I learned to be proactive rather than reactive. I have been in remission for years now, not by ignoring medicine, but by combining it with clarity and responsibility. That experience shaped PROTOCOL. We believe health should be proactive, personal, and grounded in real data, guided by doctors and coaches who take the time to explain what actually matters. Not fear-driven. Not trend-driven. Just clear, responsible care that helps people stay healthier for longer.”

Mehdi Elaichouni, Founder & CEO, PROTOCOL

Prior to founding PROTOCOL, Mehdi spent 12 years leading marketing strategy at global firms including WPP, Omnicom, and Publicis, advising Fortune 500 companies and government clients across Asia-Pacific. He also founded Carpe Diem, a group of top-ranked martial arts studios in Singapore and home to Asia’s #1 Jiu-Jitsu team.

“What sets PROTOCOL apart is Mehdi’s conviction that health outcomes require more than an app. By integrating screening, prescription, and coaching under one roof – both physical and digital – PROTOCOL is building the kind of trusted, recurring health relationship that retains members for life. We see strong parallels to the consumer subscription models we have backed across Asia, and Mehdi brings the rare combination of brand-building expertise and personal mission that the best founders have.”

Sameer Mehta, Managing Director & Head of Southeast Asia, DSG Consumer Partners

The pre-seed funding will be allocated across three priorities: expanding the clinical and operations team to meet growing member demand, accelerating the development of PROTOCOL’s proprietary health dashboard and analytics platform with new features launching monthly, and scaling customer acquisition to position PROTOCOL as Singapore’s leading hybrid preventive care provider.

PROTOCOL is a Singapore-based medtech company making preventive care accessible to everyone. Through a hybrid model that integrates a physical clinic with a digital health platform, PROTOCOL combines advanced bloodwork screening, prescription therapies including GLP-1 and TRT, targeted supplementation, and personalised coaching to deliver data-driven healthcare built around the individual. The company’s proprietary health dashboard provides members with real-time access to their biomarker data, clinical insights, and personalised care plans. Founded in September 2025 and headquartered at 71 Robinson Road, Singapore, PROTOCOL is backed by DSG Consumer Partners and Lightspeed Venture Partners.

According to Bain & Company’s 2024 Asia-Pacific Front Line of Healthcare report, 51% of APAC consumers are now willing to pay more out of pocket for healthcare in exchange for better outcomes and continuity of care – a figure that climbs to 58% among Gen Z. PROTOCOL is built to meet that demand head-on.

For more information, visit protocolhealth.sg.